Publications by authors named "Emma D Johnson"

Claim this Profile
S
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Oriol Sibila, Jamie Stobo, Lidia Perea, Yong-Hua Gao, Jin-Fu Xu, Emma D Johnson

Lancet Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotypes of Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).
Rebecca C Hull, Jamie Stobo, Hani Abo-Leyah, Hollian Richardson, Daniela Alferes de Lima Headley, Emma D Johnson

Am J Respir Crit Care Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Emma D Johnson, Merete B Long, Lidia Perea, Vivian H Shih, Carlos Fernandez

Am J Respir Crit Care Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the future of inhaled antibiotics for bronchiectasis?
Emma D Johnson, James D Chalmers

Expert Rev Respir Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exacerbations of bronchiectasis.
Alessandro De Angelis, Emma D Johnson, Sivagurunathan Sutharsan, Stefano Aliberti

Eur Respir Rev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising antibiotic treatment duration in ventilator-associated pneumonia.
Emma D Johnson, James D Chalmers

Lancet Respir Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis